Open Access
Blood Research articles are published open access under a CC BY licence (Creative Commons Attribution 4.0 International licence).
The CC BY licence is the most open licence available and considered the industry 'gold standard' for open access; it is also preferred by many funders. This licence allows readers to copy and redistribute the material in any medium or format, and to alter, transform, or build upon the material, including for commercial use, providing the original author is credited.
Most KeyWord
?
What is Most Keyword?
- It is most registrated keyword in articles at this journal during for 2 years.
Most Read
-
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)
Christopher Chin Keong Liam, Jim Yu-Hsiang Tiao, Yee Yee Yap, Yi Lin Lee, Jameela Sathar, Simon McRae, Amanda Davis, Jennifer Curnow, Robert Bird, Philip Choi, Pantep Angchaisuksiri, Sim Leng Tien, Joyce Ching Mei Lam, Doyeun Oh, Jin Seok Kim, Sung-Soo Yoon, Raymond Siu-Ming Wong, Carolyn Lauren, Eileen Grace Merriman, Anoop Enjeti, Mark Smith, Ross Ian Baker
Blood Res 2023;58: 36-41 -
Transfusion support in hematopoietic stem cell transplantation
Dong Wook Jekarl, Jae Kwon Kim, Jay Ho Han, Howon Lee, Jaeeun Yoo, Jihyang Lim, Yonggoo Kim
Blood Res 2023;58: S1-S7
Most Cited
-
Plasmacytoid dendritic cell neoplasms
Yoo Jin Lee, Youjin Kim, Sang Hyuk Park, Jae-Cheol Jo
Blood Res 2023;58: S90-S95 -
Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase
Eun-Ji Choi
Blood Res 2023;58: S29-S36
Editorial Office
+82-2-516-6582
